Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+44.4%
5Y CAGR+95.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+44.4%/yr
vs +56.6%/yr prior
5Y CAGR
+95.9%/yr
Recent deceleration
Acceleration
-12.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
28.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $519.50M | +52.8% |
| 2024 | $339.89M | +50.0% |
| 2023 | $226.62M | +31.3% |
| 2022 | $172.62M | +58.7% |
| 2021 | $108.78M | +503.5% |
| 2020 | $18.03M | -66.5% |
| 2019 | $53.83M | +87.5% |
| 2018 | $28.71M | +214.6% |
| 2017 | $9.13M | +51.0% |
| 2016 | $6.04M | - |